4DMedical is trading at A$3.62, up 5.38%, after a stronger healthcare-sector session, with Healthcare ETF performance supplied at +1.28% as investors favored defensive healthcare amid market volatility and rate uncertainty.
- No clear company-specific announcement dated September 14–15, 2026 was identified in available official news and ASX announcement listings.
- The move therefore appears sector-led rather than driven by a confirmed 4DMedical catalyst.